Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV001329433 | SCV001520874 | uncertain significance | Aortic valve disease 2 | 2020-09-11 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Ambry Genetics | RCV002418986 | SCV002725236 | uncertain significance | Inborn genetic diseases | 2022-05-24 | criteria provided, single submitter | clinical testing | The p.Y336H variant (also known as c.1006T>C), located in coding exon 4 of the SMAD6 gene, results from a T to C substitution at nucleotide position 1006. The tyrosine at codon 336 is replaced by histidine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |